EYEGATE PHARMACEUTICALS INC (33) | Business Finance (15)
Browse by Subcategory
Recent Contracts
-
Stock Purchase Agreement, dated as of October 21, 2021, by and among EyeGate Pharmaceuticals, Inc. and the Sellers listed therein
(Filed With SEC on October 26, 2021)
-
Form of Placement Agent Warrant
(Filed With SEC on August 10, 2021)
-
Form of Securities Purchase Agreement
(Filed With SEC on August 10, 2021)
-
Patent and Know How Assignment Agreement, dated as of July 2, 2013, by and between Panoptes Pharma Ges.m.b.H and 4SC Discovery GmbH
(Filed With SEC on March 25, 2021)
-
Registration Rights Agreement between the Company and Armistice Capital Master Fund, Ltd. dated as of January 5, 2021
(Filed With SEC on January 6, 2021)
-
Share Purchase Agreement, dated as of December 18, 2020, by and among EyeGate Pharmaceuticals, Inc. and the Sellers listed therein
(Filed With SEC on December 21, 2020)
-
Form of Warrant
(Filed With SEC on August 10, 2021)
-
Securities Purchase Agreement between the Company and Armistice Capital Master Fund, Ltd. dated as of January 5, 2021
(Filed With SEC on January 6, 2021)
-
Form of Warrant
(Filed With SEC on January 6, 2021)
-
Registration Rights Agreement, dated as of December 18, 2020, by and among EyeGate Pharmaceuticals, Inc. and the Sellers listed therein
(Filed With SEC on December 21, 2020)
-
Form of Placement Agent Warrant
(Filed With SEC on December 31, 2019)
-
Form of Securities Purchase Agreement
(Filed With SEC on December 31, 2019)
-
Form of Warrant
(Filed With SEC on September 30, 2019)
-
Securities Purchase Agreement between the Company and Armistice Capital Master Fund, Ltd. dated as of September 29, 2019
(Filed With SEC on September 30, 2019)
-
Registration Rights Agreement between the Company and Armistice Capital Master Fund, Ltd. dated as of September 29, 2019
(Filed With SEC on September 30, 2019)